Clinical Trial Update: Effect of Fenofibrate on Sleep Apnea Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluated fenofibrate for Sleep Apnea Syndrome; the study was terminated and results were posted in 2009.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Obesity
• Overweight
• Sleep Apnea Syndrome

Drugs mentioned

• FENOFIBRATE (Fenofibrate)

Snippet

Sponsor: Solvay Pharmaceuticals | Conditions: Dyslipidemia, Sleep Apnea Syndrome | Phase 2 | Status: TERMINATED | Results posted: 2009-07-07